메뉴 건너뛰기




Volumn 43, Issue 2, 2010, Pages 232-243

HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin

Author keywords

Amyloid beta; Blood brain barrier; HIV 1; Human brain microvascular endothelial cells; Statins

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; LIPOPROTEIN; LIPOPROTEIN RELATED PROTEIN 1; SIMVASTATIN; UNCLASSIFIED DRUG;

EID: 73249132000     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2009.11.004     Document Type: Article
Times cited : (49)

References (41)
  • 2
    • 42449095035 scopus 로고    scopus 로고
    • Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells
    • Andras I.E., Rha G., Huang W., Eum S., Couraud P.O., Romero I.A., Hennig B., and Toborek M. Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells. Mol. Pharmacol. 73 (2008) 1424-1433
    • (2008) Mol. Pharmacol. , vol.73 , pp. 1424-1433
    • Andras, I.E.1    Rha, G.2    Huang, W.3    Eum, S.4    Couraud, P.O.5    Romero, I.A.6    Hennig, B.7    Toborek, M.8
  • 3
    • 40449141429 scopus 로고    scopus 로고
    • Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy
    • Bhaskaran K., Mussini C., Antinori A., Walker A.S., Dorrucci M., Sabin C., Phillips A., and Porter K. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann. Neurol. 63 (2008) 213-221
    • (2008) Ann. Neurol. , vol.63 , pp. 213-221
    • Bhaskaran, K.1    Mussini, C.2    Antinori, A.3    Walker, A.S.4    Dorrucci, M.5    Sabin, C.6    Phillips, A.7    Porter, K.8
  • 4
    • 0031004788 scopus 로고    scopus 로고
    • Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells
    • Blanc E.M., Toborek M., Mark R.J., Hennig B., and Mattson M.P. Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68 (1997) 1870-1881
    • (1997) J. Neurochem. , vol.68 , pp. 1870-1881
    • Blanc, E.M.1    Toborek, M.2    Mark, R.J.3    Hennig, B.4    Mattson, M.P.5
  • 6
    • 38349143353 scopus 로고    scopus 로고
    • RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease
    • Chen X., Walker D.G., Schmidt A.M., Arancio O., Lue L.F., and Yan S.D. RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease. Curr. Mol. Med. 7 (2007) 735-742
    • (2007) Curr. Mol. Med. , vol.7 , pp. 735-742
    • Chen, X.1    Walker, D.G.2    Schmidt, A.M.3    Arancio, O.4    Lue, L.F.5    Yan, S.D.6
  • 8
    • 34147183707 scopus 로고    scopus 로고
    • Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
    • Deane R., and Zlokovic B.V. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 4 (2007) 191-197
    • (2007) Curr. Alzheimer Res. , vol.4 , pp. 191-197
    • Deane, R.1    Zlokovic, B.V.2
  • 10
    • 7644225312 scopus 로고    scopus 로고
    • RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier
    • Deane R., Wu Z., and Zlokovic B.V. RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke 35 (2004) 2628-2631
    • (2004) Stroke , vol.35 , pp. 2628-2631
    • Deane, R.1    Wu, Z.2    Zlokovic, B.V.3
  • 13
    • 32944456977 scopus 로고    scopus 로고
    • Statins could be used to control replication of some viruses, including HIV-1
    • Gilbert C., Bergeron M., Methot S., Giguere J.F., and Tremblay M.J. Statins could be used to control replication of some viruses, including HIV-1. Viral Immunol. 18 (2005) 474-489
    • (2005) Viral Immunol. , vol.18 , pp. 474-489
    • Gilbert, C.1    Bergeron, M.2    Methot, S.3    Giguere, J.F.4    Tremblay, M.J.5
  • 15
    • 15944397586 scopus 로고    scopus 로고
    • Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients
    • Green D.A., Masliah E., Vinters H.V., Beizai P., Moore D.J., and Achim C.L. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19 (2005) 407-411
    • (2005) AIDS , vol.19 , pp. 407-411
    • Green, D.A.1    Masliah, E.2    Vinters, H.V.3    Beizai, P.4    Moore, D.J.5    Achim, C.L.6
  • 16
    • 33846639179 scopus 로고    scopus 로고
    • Statins and the vascular endothelial inflammatory response
    • Greenwood J., and Mason J.C. Statins and the vascular endothelial inflammatory response. Trends Immunol. 28 (2007) 88-98
    • (2007) Trends Immunol. , vol.28 , pp. 88-98
    • Greenwood, J.1    Mason, J.C.2
  • 18
    • 33749498028 scopus 로고    scopus 로고
    • Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells
    • Hamel F.G., Fawcett J., Tsui B.T., Bennett R.G., and Duckworth W.C. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells. Diabetes Obes. Metab. 8 (2006) 661-668
    • (2006) Diabetes Obes. Metab. , vol.8 , pp. 661-668
    • Hamel, F.G.1    Fawcett, J.2    Tsui, B.T.3    Bennett, R.G.4    Duckworth, W.C.5
  • 19
    • 38349147618 scopus 로고    scopus 로고
    • Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice
    • Herring A., Yasin H., Ambree O., Sachser N., Paulus W., and Keyvani K. Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice. Brain Pathol. 18 (2008) 32-39
    • (2008) Brain Pathol. , vol.18 , pp. 32-39
    • Herring, A.1    Yasin, H.2    Ambree, O.3    Sachser, N.4    Paulus, W.5    Keyvani, K.6
  • 24
    • 67649099340 scopus 로고    scopus 로고
    • HIV regulation of amyloid beta production
    • Pulliam L. HIV regulation of amyloid beta production. J. Neuroimmune Pharmacol. 4 (2009) 213-217
    • (2009) J. Neuroimmune Pharmacol. , vol.4 , pp. 213-217
    • Pulliam, L.1
  • 25
    • 35648986681 scopus 로고    scopus 로고
    • Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate
    • Rangachari V., Moore B.D., Reed D.K., Sonoda L.K., Bridges A.W., Conboy E., Hartigan D., and Rosenberry T.L. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate. Biochemistry 46 (2007) 12451-12462
    • (2007) Biochemistry , vol.46 , pp. 12451-12462
    • Rangachari, V.1    Moore, B.D.2    Reed, D.K.3    Sonoda, L.K.4    Bridges, A.W.5    Conboy, E.6    Hartigan, D.7    Rosenberry, T.L.8
  • 26
    • 15744363144 scopus 로고    scopus 로고
    • HIV-1 Tat inhibits neprilysin and elevates amyloid beta
    • Rempel H.C., and Pulliam L. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19 (2005) 127-135
    • (2005) AIDS , vol.19 , pp. 127-135
    • Rempel, H.C.1    Pulliam, L.2
  • 27
    • 34547380204 scopus 로고    scopus 로고
    • Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    • Rogers J., Mastroeni D., Leonard B., Joyce J., and Grover A. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?. Int. Rev. Neurobiol. 82 (2007) 235-246
    • (2007) Int. Rev. Neurobiol. , vol.82 , pp. 235-246
    • Rogers, J.1    Mastroeni, D.2    Leonard, B.3    Joyce, J.4    Grover, A.5
  • 33
    • 0242322487 scopus 로고    scopus 로고
    • Modulation of the LDL receptor and LRP levels by HIV protease inhibitors
    • Tran H., Robinson S., Mikhailenko I., and Strickland D.K. Modulation of the LDL receptor and LRP levels by HIV protease inhibitors. J. Lipid Res. 44 (2003) 1859-1869
    • (2003) J. Lipid Res. , vol.44 , pp. 1859-1869
    • Tran, H.1    Robinson, S.2    Mikhailenko, I.3    Strickland, D.K.4
  • 36
    • 67649085899 scopus 로고    scopus 로고
    • The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era
    • Xu J., and Ikezu T. The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J. Neuroimmune Pharmacol 4 (2009) 200-212
    • (2009) J. Neuroimmune Pharmacol , vol.4 , pp. 200-212
    • Xu, J.1    Ikezu, T.2
  • 40
    • 46749099351 scopus 로고    scopus 로고
    • New therapeutic targets in the neurovascular pathway in Alzheimer's disease
    • Zlokovic B.V. New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics 5 (2008) 409-414
    • (2008) Neurotherapeutics , vol.5 , pp. 409-414
    • Zlokovic, B.V.1
  • 41
    • 0033943469 scopus 로고    scopus 로고
    • Clearance of amyloid beta-peptide from brain: transport or metabolism?
    • Zlokovic B.V., Yamada S., Holtzman D., Ghiso J., and Frangione B. Clearance of amyloid beta-peptide from brain: transport or metabolism?. Nat. Med. 6 (2000) 718-719
    • (2000) Nat. Med. , vol.6 , pp. 718-719
    • Zlokovic, B.V.1    Yamada, S.2    Holtzman, D.3    Ghiso, J.4    Frangione, B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.